Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

This publication has 21 references indexed in Scilit:

• Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
  Antimicrobial Agents and Chemotherapy, 2014
• Clinical Outcomes with Ertapenem as a First-Line Treatment Option of Infections Caused by Extended-Spectrum β-Lactamase Producing Gram-Negative Bacteria
  Annals of Pharmacotherapy, 2012
• Extended-spectrum β-lactamase-producing organisms
  Journal of Hospital Infection, 2009
• Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns
  Infection Control & Hospital Epidemiology, 2009
• Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
  Infection Control & Hospital Epidemiology, 2008
• Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline
  Journal of Antimicrobial Chemotherapy, 2007
• Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase– and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997–2004)
  Diagnostic Microbiology and Infectious Disease, 2005
• Extended-Spectrum β-Lactamases: a Clinical Update
  Clinical Microbiology Reviews, 2005
• Variations in the Prevalence of Strains Expressing an Extended‐Spectrum β‐Lactamase Phenotype and Characterization of Isolates from Europe, the Americas, and the Western Pacific Region
  Clinical Infectious Diseases, 2001
• The Trometamol Salt of Fosfomycin: Microbiological Evaluation
  European Urology, 1987